pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['kn671']
great to finally see kn671 presented by . gem/pem chemo backbone #4. ia1 efs presented. 74% had #4. 82% had surgery. 73% had adjuvant. 11% pneumonectomy. hr 0.58 efs. pdl1 predictive. pcr 18.1% and mpr 30.2% predictive. 5.1% discontinuation for aes. #asco23 
Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own.